Duke doctor: Stem cell therapy might help heart disease patients
By daniellenierenberg
Durham, N.C. People with heart disease have more treatment options than ever. However, sometimes nothing gets rid of continued chest pain known as angina. Researchers say they are looking at a special stem cell therapy to help those patients.
Danny Darden, 49, has heart disease and frequent chest pain despite two years worth of every treatment, surgery and medication available to stop it.
If I walk around the block, I give out and have chest pains, he said.
Duke cardiologist Dr. Tom Povsic included Darden in a phase 3 trial looking for benefits of a special stem cell therapy to stimulate the growth of new vessels feeding blood to the heart.
In certain patients, the arteries can no longer be fixed, or bypass surgery can't be used to fix the arteries. And in those patients, novel therapies are sorely needed, Povsic said. So, the stem cells in this particular case are obtained from the patient themselves.
The cells, originating in the bone marrow, are stimulated and released into the blood stream, extracted and then administered directly into the heart through a special catheter.
Last week, I was injected with the stem cells, Darden said. I'm excited to be in it, because I feel it's going to work, and even if it (doesnt) work for me, it's going to work for other people.
The study is blind, meaning Darden may have received a fake infusion. Participants are followed for two years. A smaller previous study showed promising results.
The benefit that was seen in the early study far exceeds what was seen with many medicines that are approved for angina relief, Povsic said.
Researchers say if the stem cell therapy benefits are confirmed in patients with angina, it could also be studied in patients dealing with stroke, heart attack or heart failure.
Here is the original post:
Duke doctor: Stem cell therapy might help heart disease patients
Stem Cell Therapy Boston – New England Center for Hair Restoration – Video
By JoanneRUSSELL25
Stem Cell Therapy Boston - New England Center for Hair Restoration
At New England Center for Hair Restoration, our Boston area specialists are working with stem cell therapy in a research environment to discover the many ways it can assist in treating hair loss. We expect to see phenomenal results, as we have already discovered many reasons as to why stem cells can be effective as a hair loss solution. If you are interested in learning more about stem cell therapy, or any other hair loss treatments available at our Boston hair restoration center, please visit http://www.nehair.com. You may contact our hair loss center at 465 S. Washington Street North Attleborough, MA 02760 (855) 563-4247, (855) 5 NE HAIR http://www.nehair.com
By: Ryan Welter
See the rest here:
Stem Cell Therapy Boston - New England Center for Hair Restoration - Video
Stem Cell Therapy Bio1103 Group 29 AM – Video
By NEVAGiles23
Stem Cell Therapy Bio1103 Group 29 AM
Peyton Manning and Stem Cell Research
By: megmitchell93
See original here:
Stem Cell Therapy Bio1103 Group 29 AM - Video
Group 52AM- Stem Cell Therapy – Video
By JoanneRUSSELL25
Group 52AM- Stem Cell Therapy
Group 52 (BIOL1103/11:00AM) clearly illustrates the topic of Stem Cell Therapy through a class project based on a member of their own group who is considering Stem Cell Therapy.
By: Savannah Kelley
Follow this link:
Group 52AM- Stem Cell Therapy - Video
Age-Related Macular Degeneration and Retinal Stem Cell Therapy – Video
By NEVAGiles23
Age-Related Macular Degeneration and Retinal Stem Cell Therapy
The problems of AMD and its potential treatment with Retinal Stem Cell Therapy BIO 1103 at UGA
By: grayson3447
Continue reading here:
Age-Related Macular Degeneration and Retinal Stem Cell Therapy - Video
Philippine-based group warns on stem cell medicine
By daniellenierenberg
Manila: A Philippine-based group has aired concern over the dangers of stem cell treatment as it warned of the possibility that materials being used for such procedures could have been extracted from hapless donors, particularly human foetuses.
Dr Leo Olarte, spokesman of the Philippine Society for Stem Cell Medicine, said they were alarmed over reports coming locally and from abroad that some stem cell materials were being taken from the unborn.
At the same time he called on the Department of Health to carefully watch stem cell treatment practitioners. The Catholic Church, he said, should unite with health practitioners and put an end to such practices.
Olarte was quoted as saying in reports that allogenic stem cells from aborted foetuses of humans were being exported to the Philippines.
Article continues below
We cannot stand by and merely watch how they exploit people in poverty just to profit while allowing others who are economically well off to benefit from this, he said.
He said there were reports that human stem cells from foetuses and female egg cells were being used in anti-ageing procedures and other medical treatments.
Olarte is also concerned over the sale of supposedly stem cell products that come in the form of injectibles and even soaps.
Dont patronise those products. An example is the stem cell soap. It is unfair that stem cell therapy becomes a quackery, he said.
Earlier, Department of Health Secretary Enrique Ona led a national convention participated in by doctors to discuss the truth behind stem cell therapy.
Originally posted here:
Philippine-based group warns on stem cell medicine
Group 62AM Alzheimer’s Stem Cell Therapy – Video
By Sykes24Tracey
Group 62AM Alzheimer #39;s Stem Cell Therapy
Group 62AM #39;s video for Biology 1103 at UGA
By: Brooke Dillard
View original post here:
Group 62AM Alzheimer's Stem Cell Therapy - Video
USDA announces movement of biotechnology approvals – Agri-Pulse
By Dr. Matthew Watson
USDA announces movement of biotechnology approvals Agri-Pulse 22, 2013— U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) today announced several biotechnology regulatory actions sent to the Federal Register for publication. According to APHIS, the agency is making the ... USDA ANNOUNCES AVAILABILITY OF BIOTECHNOLOGY REGULATORY ...PoliticalNews.me (press release) |
Crop biotechnology: A ‘continuing success’ globally – Business Mirror
By Dr. Matthew Watson
Crop biotechnology: A 'continuing success' globally Business Mirror CROP biotechnology has been achieving “continuing success” globally as the number of farmers who use it and the farms planted to biotech crops are increasing, recording 17.3 million farmers who planted the crops in 170.3 hectares in 28 countries in ... |
Biotechnology Competition: Winners – HispanicBusiness.com
By Dr. Matthew Watson
![]() HispanicBusiness.com | Biotechnology Competition: Winners HispanicBusiness.com Business, law, science and medical students from top universities around the nation converged at the Wake Forest University Schools of Business on February 8-9 for the 4th Annual Biotechnology Conference and Case Competition. The eight student teams ... |
Never a better time to eat a burger – Irish Times
By Dr. Matthew Watson
![]() Irish Times | Never a better time to eat a burger Irish Times There has never been a better time to dust down your CV if you have experience in animal or molecular genetics. DNA testing laboratories, such as Identigen in Dublin, cannot keep up with the demand for testing from the industry and regulators. DNA ... |
W.Va. fisheries biologists using new methods – San Francisco Chronicle
By Dr. Matthew Watson
W.Va. fisheries biologists using new methods San Francisco Chronicle "With the techniques developed in the field of molecular genetics, we are able to tell why some strains of fish do better than others. It started in the early 1980s when people started studying Florida-strain largemouth bass, and it just exploded from ... |
Concerns over spread of antibiotic resistant genes – Horsetalk
By Dr. Matthew Watson
![]() Horsetalk | Concerns over spread of antibiotic resistant genes Horsetalk ... known as ARGs, some at levels 192 to 28,000 times higher than the control samples, said study co-author James Tiedje, Michigan State University Distinguished Professor of microbiology and molecular genetics and of plant, soil and microbial sciences. |
Know Your Neighors: Understanding the Muslim Community in Twin Falls – Twin Falls Times-News
By Dr. Matthew Watson
Know Your Neighors: Understanding the Muslim Community in Twin Falls Twin Falls Times-News He holds a doctorate degree in plant molecular genetics from University of Helsinki in Finland and the Scottish Crop Research Institute. Eujayl immigrated to the United States when his name was drawn in the U.S. Diversity Immigrant Visa program (Visa ... |
Silicon Valley Tycoons Bestow Surprise $33 Million Prize On 11 Unsuspecting … – Popular Science
By Dr. Matthew Watson
![]() Popular Science | Silicon Valley Tycoons Bestow Surprise $33 Million Prize On 11 Unsuspecting ... Popular Science Hans Clevers, Professor of Molecular Genetics at Hubrecht Institute; For describing the role of Wnt signaling in tissue stem cells and cancer. Titia de Lange, Leon Hess Professor, Head of the Laboratory of Cell Biology and Genetics, and Director of the ... Mark Zuckerberg, Sergey Brin, Other Tech Moguls Launch 'Breakthrough Prize ...Huffington Post Breakthrough Prize: Mark Zuckerberg, Sergey Brin And Others Launch Huge ...Huffington Post UK |
Speaking for "Answers in Genesis," Creationist Georgia Purdom Hits a Nail on … – Discovery Institute
By Dr. Matthew Watson
![]() Discovery Institute | Speaking for "Answers in Genesis," Creationist Georgia Purdom Hits a Nail on ... Discovery Institute That's a distinction that many Darwinists egregiously and intentionally muddle, leaving the media and much of the public confused. Dr. Purdom, who has her degree in molecular genetics, works with the organization Answers in Genesis. In a brief video ... |
Cure for Common Hangover? ‘Pill’ Mimics Action of Human Liver in Fighting … – Science Daily (press release)
By Dr. Matthew Watson
Cure for Common Hangover? 'Pill' Mimics Action of Human Liver in Fighting ... Science Daily (press release) Additional authors of the research include Wei Wei of UCLA Engineering; Ming Yan of UCLA Engineering and the UCLA Department of Microbiology, Immunology and Molecular Genetics; Mo Yin Lau, Jay Hu, Hui Han and Cheng Ji of the Keck School of ... |
City of Hope Exec Will Leave California Stem Cell Agency Board
By Dr. Matthew Watson
![]() |
Michael Friedman City of Hope photo |
California stem cell agency will lose another one of its veteran
members this year – Michael Friedman, the CEO of the City of Hope
in the Los Angeles area.
the board. Pomeroy is resigning as vice chancellor of Human Health
Services at UC Davis this spring to become president of the Lasker Foundation in New York.. Friedman is retiring at the end of this year.
its first meeting in December 2004. Pomeroy was appointed by the UC
Davis chancellor. Friedman was appointed by the state treasurer.
likely successors. However, the UC Davis chancellor is required by
law to appoint an executive officer from the campus. The new dean at
the UCD medical school would seem to be the most likely candidate.
Lockyer must appoint an executive officer from a California research
institute. The tradition on the board has been for particular
institutes to hold particular seats on the board. The major exception
is the Salk Institute, which lost a seat on the board a few years
back.
benefited enormously from CIRM largess. UC Davis has received $131
million and the City of Hope $51 million. Although Friedman and
Pomeroy have not been allowed to vote on grants to their
institutions, their presence and the presence on the board of other executives
from beneficiary institutions has triggered calls for sweeping changes at the agency.
of Medicine said “far too many” board members are linked to
institutions that receive money from CIRM. The institute recommended
that a new majority of independent members be created on the board.
California Stem Cell Report, about 90 percent of the $1.8 billion the
board has awarded has gone to institutions with ties to past and
present board members. Fifteen of the 29 members of the board, which
has no independent members along the lines suggested by the IOM, are
linked to recipient institutions.
before money for new awards runs out in less than four years.
Monitoring the Cash and IP at the California Stem Cell Agency
By Dr. Matthew Watson
The $3 billion California stem cell
agency appears unlikely to make any changes in who gets the cash from
any commercial products that its research grants help finance despite
recommendations from the Institute of Medicine(IOM).
during a meeting of the intellectual property subcommittee of the
governing board of the stem cell agency. Intellectual property (IP) simply
determines ownership rights and the share of any revenue from
therapies that result from research.
teleconference locations in La Jolla, Los Angeles, two in Irvine
along with the main site in San Francisco.
recommendations in this fashion:
“Because CIRM is a new institution
without a track record to reassure stakeholders, and because its
finite funding timeline means as yet unknown agencies will be
enforcing these policies years down the road, CIRM should “propose
regulations that specify who will have the power and authority to
assert and enforce in the future rights retained by the state” in
CIRM IP, specifically referring to march-in rights, access plans and
revenue sharing....
“Second, as other sources of funding
become more prevalent, the agency should “reconsider whether its
goal of developing cures would be better served by harmonizing CIRM’s
IP policies wherever possible with the more familiar policies of the
BayhDole Act.”
recommendations.
“CIRM staff has engaged in
preliminary discussions several years ago with other agencies
regarding future enforcement of CIRM’s regulations and agreements.
Staff proposes to restart those discussions and return to the
Subcommittee (or the Board) with a formal proposal to address future
enforcement of CIRM’s IP regulations.”“In light of the IOM’s own
recognition that it may be premature to assess whether CIRM’s
regulations will act as a deterrence to future investment, the fact
that a number of CIRM’s regulations have been codified in statutes
and CIRM’s positive progress in its industry engagement efforts to
date, although quite early, CIRM staff proposes to continue to
monitor this area and not to pursue any changes at this time.”
to diverge significantly from the staff proposal, which was dated
Feb. 14 but not posted on the CIRM website until Feb. 20.
Half-full, Half-empty Editorial on California Stem Cell Agency
By Dr. Matthew Watson
The California stem cell agency's
editorial road show paid off a bit again this week with a mildly
approving editorial in the Oakland Tribune.
of Jonathan Thomas, a Los Angeles bond financier, as chairman of the
$3 billion agency has improved things, compared to the reign of Bob
Klein, who “built a protective shield” around the agency's
governing board and prevented action to deal with obvious
conflict-of-interest problems.
extent” the agency has brought “cutting edge” scientists to the
state and helped boost the stem cell field.
editorial. The half-empty side included the headline.
“California
must get its stem cell house in order”
“...{T)he agency must prove that it
understands how to properly handle the public's money. …. If
the stem cell agency can establish a record as a good steward of
public dollars to finance brilliant science, it can continue to play
a useful role in stimulating and guiding research to bring the
potential cures from stem cell research to fruition.
“If it cannot do that, it will be
just another expensive Tyrannosaurus rex.”
editorial doors around the state in hopes of building support for the
board's modest – some might say inadequate – response to
recommendations for sweeping changes at the agency.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/tMt6gs55Yvs/half-full-half-empty-editorial-on.html